Communication

News

Medisim analytix – new member

5 December 2024
News

At MediSim, we specialize in pharmacometrics, MIDD (Model-Informed Drug Development) to:

  • De-risk drug development decisions with data-driven insights (PKPD, PopPK, PBPK, QSP model)
  • Provide tailored strategies for every stage of the drug development cycle
  • Anticipate regulatory expectations (FDA / EMA filing packages)
    Our mission : Empower biotech, Pharma, and healthcare organizations to bring life-changing therapies to patients faster, smarter, and more efficiently. To know more